SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 29.39%480.76M | 28.20%471.68M | 17.17%421.33M | 33.69%357.84M | 33.69%357.84M | -33.21%371.56M | -37.44%367.93M | -49.20%359.58M | -51.55%267.67M | -51.55%267.67M |
-Cash and cash equivalents | 25.48%384.34M | 26.97%372.45M | -9.80%324.33M | 1.55%271.81M | 1.55%271.81M | -44.95%306.29M | -8.21%293.33M | 94.04%359.58M | 106.84%267.67M | 106.84%267.67M |
-Short-term investments | 47.74%96.42M | 33.02%99.23M | --97.01M | --86.03M | --86.03M | --65.27M | -72.23%74.6M | ---- | --0 | --0 |
Receivables | 42.50%87.27M | 57.78%83.94M | 46.66%80.02M | 33.91%73.39M | 33.91%73.39M | 17.89%61.25M | 0.57%53.2M | -65.07%54.56M | 44.56%54.81M | 44.56%54.81M |
-Accounts receivable | 235.29%24.65M | 180.88%22.73M | 76.70%13.38M | 76.24%9.93M | 76.24%9.93M | 43.24%7.35M | 46.05%8.09M | 6.18%7.57M | -20.83%5.64M | -20.83%5.64M |
-Related party accounts receivable | 12.93%47.12M | 42.18%46.8M | 55.03%49.49M | 51.26%51.43M | 51.26%51.43M | 32.00%41.73M | 2.47%32.91M | 40.45%31.92M | 55.44%34M | 55.44%34M |
-Other receivables | 27.42%15.51M | 18.22%14.42M | 13.82%17.15M | -20.72%12.03M | -20.72%12.03M | -20.00%12.17M | -19.96%12.2M | -88.07%15.07M | 70.08%15.17M | 70.08%15.17M |
Inventory | 40.77%23.69M | 36.74%21.91M | 28.07%20.1M | 52.25%24.51M | 52.25%24.51M | 6.12%16.83M | 10.94%16.02M | 26.69%15.69M | 27.98%16.1M | 27.98%16.1M |
Prepaid assets | 11.86%1.58M | -29.11%1.87M | 59.04%2.34M | 45.96%1.92M | 45.96%1.92M | -41.31%1.41M | -17.94%2.64M | -23.57%1.47M | -35.43%1.31M | -35.43%1.31M |
Other current assets | -22.20%36.68M | -19.32%38.72M | 2.24%39.34M | 50.37%44.12M | 50.37%44.12M | 61.22%47.15M | 59.58%47.99M | 24.60%38.48M | 7.91%29.34M | 7.91%29.34M |
Total current assets | 26.45%629.99M | 26.72%618.12M | 19.87%563.13M | 34.70%501.77M | 34.70%501.77M | -25.51%498.2M | -30.49%487.78M | -49.08%469.79M | -41.10%372.52M | -41.10%372.52M |
Non current assets | ||||||||||
Net PPE | 19.46%3.51B | 15.07%3.31B | 8.57%3.13B | 4.68%3.05B | 4.68%3.05B | 0.30%2.94B | -2.71%2.88B | -0.80%2.89B | -0.98%2.91B | -0.98%2.91B |
-Gross PPE | 16.90%4.93B | 13.77%4.69B | 9.22%4.48B | 6.48%4.36B | 6.48%4.36B | 3.10%4.22B | 0.97%4.12B | 2.46%4.1B | 2.37%4.09B | 2.37%4.09B |
-Accumulated depreciation | -10.99%-1.42B | -10.76%-1.38B | -10.76%-1.34B | -10.93%-1.31B | -10.93%-1.31B | -10.17%-1.28B | -10.64%-1.25B | -11.14%-1.21B | -11.67%-1.18B | -11.67%-1.18B |
Investments and advances | --0 | -93.17%64K | -90.39%161K | --270K | --270K | --411K | --937K | --1.68M | --0 | --0 |
Related parties assets | 12.93%47.12M | 42.18%46.8M | 55.03%49.49M | 51.26%51.43M | 51.26%51.43M | 32.00%41.73M | 2.47%32.91M | 40.45%31.92M | 55.44%34M | 55.44%34M |
Non current deferred assets | 35.69%46.13M | 24.45%39.55M | 14.65%36.07M | 48.75%38.01M | 48.75%38.01M | 79.37%34M | 103.63%31.78M | 71.58%31.46M | 116.54%25.55M | 116.54%25.55M |
Other non current assets | -20.55%62.95M | -10.49%77.13M | -16.80%76.52M | -19.23%72.63M | -19.23%72.63M | 5.12%79.23M | 37.49%86.17M | 71.94%91.96M | 115.44%89.92M | 115.44%89.92M |
Total non current assets | 18.59%3.62B | 14.40%3.43B | 7.81%3.25B | 4.35%3.16B | 4.35%3.16B | 0.93%3.06B | -1.31%3B | 1.00%3.01B | 1.10%3.03B | 1.10%3.03B |
Total assets | 19.69%4.25B | 16.13%4.05B | 9.43%3.81B | 7.67%3.66B | 7.67%3.66B | -3.85%3.55B | -6.79%3.48B | -10.83%3.48B | -6.26%3.4B | -6.26%3.4B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 37.10%24.82M | 34.40%23.57M | -5.20%22.25M | -6.88%22.82M | -6.88%22.82M | -2.01%18.1M | -5.53%17.53M | 8.07%23.47M | 29.48%24.51M | 29.48%24.51M |
-accounts payable | 37.10%24.82M | 34.40%23.57M | -5.20%22.25M | -6.88%22.82M | -6.88%22.82M | -2.01%18.1M | -5.53%17.53M | 8.07%23.47M | 29.48%24.51M | 29.48%24.51M |
Current accrued expenses | -0.16%16.66M | 12.47%24.64M | -11.02%15.18M | -4.23%20.46M | -4.23%20.46M | -19.11%16.68M | -18.08%21.91M | -46.01%17.06M | -20.86%21.36M | -20.86%21.36M |
Current debt and capital lease obligation | 30.00%31.72M | -8.51%25.16M | -77.98%20.5M | -61.25%21.3M | -61.25%21.3M | -75.25%24.4M | -76.65%27.5M | -48.36%93.09M | -69.72%54.97M | -69.72%54.97M |
-Current debt | 30.00%31.72M | -8.51%25.16M | -25.47%20.5M | -22.55%21.3M | -22.55%21.3M | -65.87%24.4M | -61.54%27.5M | -70.79%27.5M | -71.28%27.5M | -71.28%27.5M |
-Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -23.83%65.59M | -67.99%27.47M | -67.99%27.47M |
Current deferred liabilities | -23.30%58.65M | -42.69%51.53M | -44.98%54.84M | -42.58%63.82M | -42.58%63.82M | -43.06%76.47M | -41.66%89.91M | 42.74%99.68M | 33.62%111.15M | 33.62%111.15M |
Other current liabilities | -23.69%28.56M | -19.01%22.86M | 63.74%32.05M | 142.11%39.76M | 142.11%39.76M | 129.44%37.42M | 49.49%28.22M | 2.49%19.58M | 89.96%16.42M | 89.96%16.42M |
Current liabilities | -7.32%160.41M | -20.17%147.75M | -42.73%144.82M | -26.38%168.16M | -26.38%168.16M | -39.96%173.08M | -44.93%185.07M | -21.59%252.88M | -28.47%228.41M | -28.47%228.41M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 67.59%647.28M | 39.78%544.54M | 8.96%431.49M | -14.34%382.87M | -14.34%382.87M | -53.26%386.22M | -54.08%389.56M | -64.60%396M | -61.28%446.98M | -61.28%446.98M |
-Long term debt | 67.59%647.28M | 39.78%544.54M | 8.96%431.49M | -4.86%382.87M | -4.86%382.87M | -50.16%386.22M | -50.70%389.56M | -60.32%396M | -60.46%402.44M | -60.46%402.44M |
-Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -67.37%44.54M | -67.37%44.54M |
Non current deferred liabilities | -58.31%29.7M | -52.93%38.75M | -48.26%49.28M | -46.10%60.13M | -46.10%60.13M | -45.45%71.23M | -46.03%82.33M | 232.94%95.24M | 193.77%111.56M | 193.77%111.56M |
Other non current liabilities | -3.33%30M | 0.30%38.1M | -27.02%34.27M | -36.34%33.65M | -36.34%33.65M | 9.60%31.03M | 178.82%37.98M | 441.95%46.96M | 1,534.54%52.86M | 1,534.54%52.86M |
Total non current liabilities | 44.73%706.97M | 21.87%621.39M | -4.30%515.04M | -22.04%476.66M | -22.04%476.66M | -50.42%488.49M | -49.74%509.88M | -54.26%538.21M | -49.88%611.41M | -49.88%611.41M |
Total liabilities | 31.11%867.38M | 10.68%769.14M | -16.59%659.86M | -23.22%644.82M | -23.22%644.82M | -48.05%661.57M | -48.55%694.95M | -47.23%791.09M | -45.43%839.81M | -45.43%839.81M |
Shareholders'equity | ||||||||||
Share capital | -1.03%193K | -2.03%193K | -4.43%194K | -4.43%194K | -4.43%194K | -3.47%195K | -3.90%197K | -1.93%203K | -1.93%203K | -1.93%203K |
-common stock | -1.03%193K | -2.03%193K | -4.43%194K | -4.43%194K | -4.43%194K | -3.47%195K | -3.90%197K | -1.93%203K | -1.93%203K | -1.93%203K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 22.16%2.77B | 23.89%2.66B | 25.76%2.54B | 27.33%2.4B | 27.33%2.4B | 29.66%2.27B | 26.63%2.15B | 18.35%2.02B | 35.84%1.89B | 35.84%1.89B |
Paid-in capital | -1.00%688.65M | -3.37%688.12M | -7.81%687.63M | -7.74%690.19M | -7.74%690.19M | -6.32%695.59M | -6.26%712.15M | -3.23%745.91M | -2.93%748.11M | -2.93%748.11M |
Gains losses not affecting retained earnings | -2.16%-72.47M | -2.23%-73.65M | -2.30%-74.81M | -2.39%-75.98M | -2.39%-75.98M | -3.19%-70.94M | -3.42%-72.04M | -3.64%-73.13M | -3.85%-74.21M | -3.85%-74.21M |
Total stockholders'equity | 17.08%3.39B | 17.48%3.28B | 17.09%3.15B | 17.81%3.02B | 17.81%3.02B | 19.38%2.89B | 16.84%2.79B | 11.86%2.69B | 22.62%2.56B | 22.62%2.56B |
Total equity | 17.08%3.39B | 17.48%3.28B | 17.09%3.15B | 17.81%3.02B | 17.81%3.02B | 19.38%2.89B | 16.84%2.79B | 11.86%2.69B | 22.62%2.56B | 22.62%2.56B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |